314 related articles for article (PubMed ID: 15183348)
1. Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation.
Sluis-Cremer N; Arion D; Abram ME; Parniak MA
Int J Biochem Cell Biol; 2004 Sep; 36(9):1836-47. PubMed ID: 15183348
[TBL] [Abstract][Full Text] [Related]
2. Glutamic residue 438 within the protease-sensitive subdomain of HIV-1 reverse transcriptase is critical for heterodimer processing in viral particles.
Navarro JM; Damier L; Boretto J; Priet S; Canard B; Quérat G; Sire J
Virology; 2001 Nov; 290(2):300-8. PubMed ID: 11883194
[TBL] [Abstract][Full Text] [Related]
3. Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.
Abram ME; Parniak MA
J Virol; 2005 Sep; 79(18):11952-61. PubMed ID: 16140771
[TBL] [Abstract][Full Text] [Related]
4. Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.
Wapling J; Moore KL; Sonza S; Mak J; Tachedjian G
J Virol; 2005 Aug; 79(16):10247-57. PubMed ID: 16051818
[TBL] [Abstract][Full Text] [Related]
5. Disruption of a salt bridge between Asp 488 and Lys 465 in HIV-1 reverse transcriptase alters its proteolytic processing and polymerase activity.
Goobar-Larsson L; Bäckbro K; Unge T; Bhikhabhai R; Vrang L; Zhang H; Orvell C; Strandberg B; Oberg B
Virology; 1993 Oct; 196(2):731-8. PubMed ID: 7690504
[TBL] [Abstract][Full Text] [Related]
6. Efavirenz enhances the proteolytic processing of an HIV-1 pol polyprotein precursor and reverse transcriptase homodimer formation.
Tachedjian G; Moore KL; Goff SP; Sluis-Cremer N
FEBS Lett; 2005 Jan; 579(2):379-84. PubMed ID: 15642347
[TBL] [Abstract][Full Text] [Related]
7. The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs.
Auwerx J; Van Nieuwenhove J; Rodríguez-Barrios F; de Castro S; Velázquez S; Ceccherini-Silberstein F; De Clercq E; Camarasa MJ; Perno CF; Gago F; Balzarini J
FEBS Lett; 2005 Apr; 579(11):2294-300. PubMed ID: 15848161
[TBL] [Abstract][Full Text] [Related]
8. The mutation T477A in HIV-1 reverse transcriptase (RT) restores normal proteolytic processing of RT in virus with Gag-Pol mutated in the p51-RNH cleavage site.
Abram ME; Sarafianos SG; Parniak MA
Retrovirology; 2010 Feb; 7():6. PubMed ID: 20122159
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions.
Olivares I; Mulky A; Boross PI; Tözsér J; Kappes JC; López-Galíndez C; Menéndez-Arias L
J Mol Biol; 2007 Sep; 372(2):369-81. PubMed ID: 17651754
[TBL] [Abstract][Full Text] [Related]
10. Relationship between enzyme activity and dimeric structure of recombinant HIV-1 reverse transcriptase.
Tachedjian G; Radzio J; Sluis-Cremer N
Proteins; 2005 Jul; 60(1):5-13. PubMed ID: 15852304
[TBL] [Abstract][Full Text] [Related]
11. In vivo processing of Pr160gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T-lymphocytes.
Lindhofer H; von der Helm K; Nitschko H
Virology; 1995 Dec; 214(2):624-7. PubMed ID: 8553565
[TBL] [Abstract][Full Text] [Related]
12. Identification of amino acid residues in HIV-1 reverse transcriptase that are critical for the proteolytic processing of Gag-Pol precursors.
Nishitsuji H; Yokoyama M; Sato H; Yamauchi S; Takaku H
FEBS Lett; 2011 Nov; 585(21):3372-7. PubMed ID: 22004763
[TBL] [Abstract][Full Text] [Related]
13. The amino acid Asn136 in HIV-1 reverse transcriptase (RT) maintains efficient association of both RT subunits and enables the rational design of novel RT inhibitors.
Balzarini J; Auwerx J; Rodríguez-Barrios F; Chedad A; Farkas V; Ceccherini-Silberstein F; García-Aparicio C; Velázquez S; De Clercq E; Perno CF; Camarasa MJ; Gago F
Mol Pharmacol; 2005 Jul; 68(1):49-60. PubMed ID: 15833734
[TBL] [Abstract][Full Text] [Related]
14. Analysis of HIV type 1 reverse transcriptase expression in a human cell line.
Ansari-Lari MA; Gibbs RA
AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1117-24. PubMed ID: 7530025
[TBL] [Abstract][Full Text] [Related]
15. Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.
Mulky A; Sarafianos SG; Arnold E; Wu X; Kappes JC
J Virol; 2004 Jul; 78(13):7089-96. PubMed ID: 15194785
[TBL] [Abstract][Full Text] [Related]
16. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.
Quillent C; Borman AM; Paulous S; Dauguet C; Clavel F
Virology; 1996 May; 219(1):29-36. PubMed ID: 8623542
[TBL] [Abstract][Full Text] [Related]
17. The p51 subunit of human immunodeficiency virus type 1 reverse transcriptase is essential in loading the p66 subunit on the template primer.
Harris D; Lee R; Misra HS; Pandey PK; Pandey VN
Biochemistry; 1998 Apr; 37(17):5903-8. PubMed ID: 9558323
[TBL] [Abstract][Full Text] [Related]
18. Spatial domain organization in the HIV-1 reverse transcriptase p66 homodimer precursor probed by double electron-electron resonance EPR.
Schmidt T; Schwieters CD; Clore GM
Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17809-17816. PubMed ID: 31383767
[TBL] [Abstract][Full Text] [Related]
19. p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors.
Dufour E; El Dirani-Diab R; Boulmé F; Fournier M; Nevinsky G; Tarrago-Litvak L; Litvak S; Andreola ML
Eur J Biochem; 1998 Jan; 251(1-2):487-95. PubMed ID: 9492322
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of HIV-1 reverse transcriptase having a 1:1 ratio of p66 and p51 subunits.
Stahlhut M; Li Y; Condra JH; Fu J; Gotlib L; Graham DJ; Olsen DB
Protein Expr Purif; 1994 Dec; 5(6):614-21. PubMed ID: 7532052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
